Survivin peptide vaccine

Details for Australian Patent Application No. 2006209951 (hide)

Owner Survac ApS

Inventors Andersen, Mads Hald

Agent Peter Maxwell & Associates

Pub. Number AU-B-2006209951

PCT Pub. Number WO2006/081826

Priority PA 2005 00173 04.02.05 DK; 60/650,751 07.02.05 US

Filing date 3 February 2006

Wipo publication date 10 August 2006

Acceptance publication date 14 April 2011

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/081826 Priority application(s): WO2006/081826

14 April 2011 Application Accepted

  Published as AU-B-2006209951

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006209977-Filter cigarette

2006209949-High density storage of ammonia